Tempus AI (TEM) Stock Price Prediction: Bullish tape meets a near-term resistance test
Tempus AI (TEM) stock traded at $76.64, up 0.10%, near resistance at $77.32. Q3 2026 revenue was $411.5M, with oncology unit growth of 32% and Data & Applications revenue growth of 33%. Needham raised its price target to $89, citing data growth. Technical indicators show mixed momentum, with support at $75.68 and resistance at $77.32.
How this was made

The 30-second read
Why it matters
Earnings and target raise provide a fresh catalyst, but technical resistance limits immediate upside, creating a short‑term trade range.
Market read
First‑report earnings with target hike give traders a new data point; price action likely to stay within $75‑$78 range pending breakout.
What to watch
Derivatives flow shows neutral funding and rising open interest, indicating potential for rapid moves if breakout fails.
Background
The article combines tokenized stock price data with fresh earnings results and analyst target adjustments for Tempus AI.
Ticker impact
Tempus AI reported Q3 2026 revenue of $411.5M and an analyst raised its price target to $89, providing fresh earnings data.
likely modest upside pressure as investors price in the higher target, but resistance at $77.32 could limit moves.
The earnings numbers and target hike are new information, but the stock is still below key resistance levels, suggesting limited immediate upside.
Market effects
Positive data for AI‑driven health‑tech may boost sentiment in the broader health‑tech and data analytics sectors.
Limited to U.S. and crypto‑linked investors tracking tokenized equities.
Modest, as Tempus AI is a micro‑cap; impact confined to niche AI‑health investors.
Counterpoint
Resistance at $77.32 is strong; a break below $75.68 could trigger a short‑term sell‑off despite the earnings beat.
Key entities
- CompanyTempus AI
AI‑driven oncology and data analytics firm, ticker TEM.
- AnalystNeedham
Raised price target to $89 following earnings.


